Jim Cramer
These 6 portfolio names pledged big U.S. investments since Trump took office again
Many of the biggest U.S. companies have pledged to invest trillions of dollars in the United States since President Donald Trump started his second term — including six names in our portfolio. These moves are aimed at aligning companies with the president’s vision for a new global trade order designed to bring manufacturing jobs back […]
Read More
Hasbro CEO details tariff impact: ‘We’re making rapid changes’
In a Thursday interview with CNBC’s Jim Cramer, Hasbro CEO Chris Cocks detailed how the toy maker is trying to diversity its supply chain and adapt to President Donald Trump’s steep tariff hikes on China, one of its top suppliers. “I think we’re making rapid changes,” he said. “You know, our goal was to get […]
Read More
These are 3 big things we’re watching in the stock market this week
The stock market bounce last week showed once again just how dependent Wall Street has become on the whims of the White House. Case in point: The S & P 500 sank more than 2% this past Monday as President Donald Trump was attacking Federal Reserve Chairman Jerome Powell and providing scant details on tariff […]
Read More
Why we’re lowering our Bristol Myers price target despite an earnings beat, guidance raise
Bristol Myers Squibb ‘s earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock. But it was enough, for now. Revenue in the first quarter, which ended March 31, dipped 6% to $11.2 billion but topped estimates of $10.7 billion, according to LSEG. Adjusted earnings per share of $1.80 beat expectations […]
Read More
Danaher’s quarterly results show signs of life, and the struggling stock soars
Danaher shares on Tuesday climbed more than 6% after the health-care company’s first-quarter results exceeded expectations — and, crucially, its guidance was left mostly intact despite an evolving economic picture. Count us among the investors breathing a sigh of relief. Revenue for the three months ended March 31 declined 1% year over year to $5.74 […]
Read More
Slowdown in tourists coming to the U.S. puts Disney’s theme park magic at risk
A slump in air travel to the U.S. is emerging in the wake of President Donald Trump’s tariffs, and it could hit Walt Disney ‘s important theme park business where it hurts. With international guests accounting for about 20% of Disney’s park attendance in Orlando, Florida, and Anaheim, California, according to Barclays, the latest data […]
Read More
What the Discover merger approval means for Capital One and 2 other financials
Capital One secured approvals from banking regulators Friday for its $35 billion acquisition of Discover Financial — a deal that analysts believe could have far-reaching benefits beyond just the Club holding. The news Wells Fargo research analysts said the greenlights from the Federal Reserve and the Office of the Comptroller of the Currency highlight a […]
Read More
These are the 4 biggest things we’re watching in the stock market in the week ahead
The stock market heads into Monday on a streak of volatility it just can’t seem to shake. What had been shaping up as a positive holiday-shortened week turned on a dime Wednesday when Federal Reserve Chairman Jerome Powell signaled concern that President Donald Trump ‘s tariffs could increase inflation and slow economic growth. Speaking at […]
Read More
Eli Lilly shares surge on new obesity pill data. What it means for the stock from here
Eli Lilly is tightening its grip on the lucrative weight-loss market as it moves into a new, more convenient phase that promises to broaden the appeal of its breakthrough drugs. The news Club name Lilly said its daily obesity pill was successful in a late-stage trial for Type 2 diabetes — sending shares soaring more […]
Read More
Abbott Labs shares surge on earnings and a big sign of confidence in the business
Shares of Abbott Laboratories jumped Wednesday after the diversified health-care company delivered strong first-quarter results and left its earnings guidance intact — a big sign of confidence in an uncertain time. Revenue in the three months ended March 31 rose 4% to $10.36 billion, narrowly missing the consensus of $10.4 billion, according to estimates compiled […]
Read More